Grant: Discovery Grants Program - Individual
University of Calgary
$85,000.00
Mechanisms of cathelicidin in gut epithelial mucin defenses during infectious colitis
FY 2024-25
Summary
Diarrheic enterocolitis caused by microbial pathogens, such as Brachyspira hyodysenteriae (swine dysentery), is a common cause of illness and death in piglets after weaning. The sustainability of the Canadian pork industry, which consists of over 14 million pigs, is directly impacted by swine dysentery with economic losses exceeding $10 per pig. This deficit arises from suppressed growth performance, mortality, and compromised animal welfare. The livestock industry is also facing increased restrictions on antibiotic use due to the rise in multi-drug resistant bacteria that cause disease in animals and humans.
My research program in veterinary innate immunology studies gut epithelial defenses of livestock. Our primary goal is to elucidate the role(s) of cathelicidins, endogenous peptides secreted by neutrophils and epithelial cells, during the pathogenesis of infectious colitis. The long-term goal is to discover anti-infective and immunomodulatory compounds to use instead of antibiotics. With preliminary data showing cathelicidin stimulates the secretion of mucin by intestinal goblet cells, my research will investigate the hypothesis that cathelicidin strengthens the colonic mucus barrier during infectious colitis. The first objective, Aim A, is to define if cathelicidin sustains the mucus layer thickening or induces changes in the glycobiology on mucin Muc2 and other glycoproteins secreted by goblet cells along the colonic crypts that enhance epithelial integrity and deter bacterial colonization. This will be accomplished using a model of colitis caused by Citrobacter rodentium, an enteropathogen related to Escherichia coli, in mice that completely lack cathelicidin or have such deficiency restricted to the intestinal epithelium or neutrophils. Studies will be complemented with in vitro analyses using colonoids and goblet like-epithelial cells. Secondly, Aim B will determine the molecular mechanisms by which cathelicidin stimulates the secretion of mucin-associated glycoproteins in goblet cells. This includes the effect of cathelicidin on transcriptional and post-translational signaling in mucin-producing goblet cells and study if cathelicidin mechanisms depend on locally generated reactive oxygen species (ROS). Lastly, Aim C will evaluate the therapeutic efficiency of exogenous cathelicidin (native or derivates) to mitigate diarrheic colitis caused by B. hyodysenteriae in weaned pigs. My training program will provide unique opportunities for highly qualified personnel to acquire expertise in mechanisms of disease and immunology in production animals.
By exploring the functions of cathelicidin in boosting the gut mucin barrier, the first protection against enteropathogens, this research will determine if cathelicidin can be developed as a gut promoter. This information is key for Canadian agriculture sustainability to mitigate losses caused by diarrhea by antibiotic-free strategies, that foster the public license to produce livestock products.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-04241
Name nom
Cobo, Eduardo
Department département
Veterinary Medicine
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
85000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Mechanisms of cathelicidin in gut epithelial mucin defenses during infectious colitis
Keywords
cathelicidin; infectious colitis; pig; diarrhea; swine dysentery; mucin barrier; host defense peptides; gut innate immunity; intestinal epithelium; immunomodulators
Application summary
Diarrheic enterocolitis caused by microbial pathogens, such as Brachyspira hyodysenteriae (swine dysentery), is a common cause of illness and death in piglets after weaning. The sustainability of the Canadian pork industry, which consists of over 14 million pigs, is directly impacted by swine dysentery with economic losses exceeding $10 per pig. This deficit arises from suppressed growth performance, mortality, and compromised animal welfare. The livestock industry is also facing increased restrictions on antibiotic use due to the rise in multi-drug resistant bacteria that cause disease in animals and humans.
My research program in veterinary innate immunology studies gut epithelial defenses of livestock. Our primary goal is to elucidate the role(s) of cathelicidins, endogenous peptides secreted by neutrophils and epithelial cells, during the pathogenesis of infectious colitis. The long-term goal is to discover anti-infective and immunomodulatory compounds to use instead of antibiotics. With preliminary data showing cathelicidin stimulates the secretion of mucin by intestinal goblet cells, my research will investigate the hypothesis that cathelicidin strengthens the colonic mucus barrier during infectious colitis. The first objective, Aim A, is to define if cathelicidin sustains the mucus layer thickening or induces changes in the glycobiology on mucin Muc2 and other glycoproteins secreted by goblet cells along the colonic crypts that enhance epithelial integrity and deter bacterial colonization. This will be accomplished using a model of colitis caused by Citrobacter rodentium, an enteropathogen related to Escherichia coli, in mice that completely lack cathelicidin or have such deficiency restricted to the intestinal epithelium or neutrophils. Studies will be complemented with in vitro analyses using colonoids and goblet like-epithelial cells. Secondly, Aim B will determine the molecular mechanisms by which cathelicidin stimulates the secretion of mucin-associated glycoproteins in goblet cells. This includes the effect of cathelicidin on transcriptional and post-translational signaling in mucin-producing goblet cells and study if cathelicidin mechanisms depend on locally generated reactive oxygen species (ROS). Lastly, Aim C will evaluate the therapeutic efficiency of exogenous cathelicidin (native or derivates) to mitigate diarrheic colitis caused by B. hyodysenteriae in weaned pigs. My training program will provide unique opportunities for highly qualified personnel to acquire expertise in mechanisms of disease and immunology in production animals.
By exploring the functions of cathelicidin in boosting the gut mucin barrier, the first protection against enteropathogens, this research will determine if cathelicidin can be developed as a gut promoter. This information is key for Canadian agriculture sustainability to mitigate losses caused by diarrhea by antibiotic-free strategies, that foster the public license to produce livestock products.